knowledge -WSS

knowledge

author：fashion 2025-09-07 06:37:42 - browse：21

light shines behind Pfizer CEO Albert Bourla as he attends a ceremony in Greece — Pfizer CEO Albert Bourla Giannis Papanikos/AP

Pfizer has a big problem. The drug giant hopes that new drugs to treat cancer are the solution.

Shares in the drugmaker fell 44% last year, and it now has a market capitalization of only $150 billion — a quarter that of Eli Lilly and half that of longtime rival Merck. In March of last year the company announced that it would spend $43 billion to buy Seagen, a maker of a hot category of oncology medicines called antibody-drug conjugates. Pfizer’s shares have slumped another 9% so far this year. On Thursday, executives are holding an investor briefing to try to convince shareholders that its bet will pay off.

In an interview with STAT, Pfizer CEO Albert Bourla was insistent that the deal’s potential is being missed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： A common UTI test for kids haunts adults as a traumatic 'nightmare'

WSS

Telehealth for opioid use disorder is lifesaving

New weight loss drugs vying to be the next Wegovy or Mounjaro

How are insurers handling Leqembi and related scans?

Digital health funding stays low as a new reality sets in

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Walmart eyes Medicare Advantage provider ChenMed

Wikipedia

knowledge

focus

Hepatitis C has a cure — but many Americans still lack access to it

One Duchenne patient's bittersweet hope for new treatment

Moonlake's readout produced a cash windfall. Risks remain

Women's World Cup brings attention to abuse in soccer

Medicare details structure of new drug price negotiation program

PEPFAR is under serious threat — and so is global health

Malaria cases in Florida and Texas: Here’s what you need to know

Long Covid needs a new name — and a new frame

Wildfire smoke exposes gaps in outdoor worker protections

Generate Biomedicines machine learning biotech raises $273M

focus

Generate Biomedicines machine learning biotech raises $273M

FDA proposes changes to key medical devices approval pathway

How are insurers handling Leqembi and related scans?

Pig kidney works a record two months in donated body

Inflation cooled significantly in June, bringing price hikes close to normal levels

Pig kidney works a record two months in donated body

focus

focus

entertainment

explore